Skip to content
★ Sign in to follow
JS

Jennifer Schranz

Nabriva Therapeutics plc
Total declarations
16
Company
1
▲ Purchases (1 ops.)
€18k
▼ Sales (0 ops.)
—

Latest filing published 02 Feb 2021 for Nabriva Therapeutics plc.

Filing timeline

BuySale
Jennifer Schranz

Insider track record

Disclosed buys
1
Disclosed sells
0
Signal history

Closed purchases

Market purchases
1

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Jennifer Schranz: trading record in brief

Jennifer Schranz is a declared insider of Nabriva Therapeutics plc, with filings sourced from SEC (Form 4). Over a trading history stretching from 22 June 2018 to 31 January 2021, the count stands at 16 filings.

On the market, this insider has only ever bought: 1 purchase, €18k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 15 share grants.

The latest filing, published on 2 February 2021, reports a share grant in Nabriva Therapeutics plc. The clock since the last published purchase (25 June 2018) now reads 3,059 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Jennifer Schranz

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations16 total

16 of 16 declarations